期刊文献+

生物转化法合成葡萄糖基抗坏血酸的产酶菌株筛选及发酵条件优化 被引量:4

Screening of α-glucosidase-producing Strain and Optimization of Its Fermentation Conditions to Produce Glucopyranosyl-L-ascorbic Acid by Biotransformation
下载PDF
导出
摘要 从土壤中筛选到1株产α-葡萄糖苷酶(EC 3.2.1.20,α-glucosidase)的菌株WPD2,通过对其进行形态学和18S rDNA序列分析及系统发育研究,该菌株初步鉴定为黑曲霉(Aspergillus nigerEU366904),该菌经产酶、转化反应后葡萄糖基抗坏血酸产量达到370 mg/L左右。摇瓶实验确定了优化后的产酶条件为:培养温度34℃,培养时间60 h,以110 g/L的麦芽糖为碳源、10 g/L的(NH4)2SO4为氮源,优化后葡萄糖基抗坏血酸产量达到410 mg/L左右。 An α-glucosidase-producing strain WPD2 was isolated from the soil, and was identified as As- pergillus niger based on morphology and phylogenetic analysis of 18S rDNA sequence. The content of ascorbic acid glucoside came to 370mg/L after biotransformation. The conditions for enzyme formation of strain WPD2 following the optimization phase were maltose 110g/L , ammonium sulphate 10g/L, culture time 60h,temperature 34℃ and the content of ascorbic acid glucoside reached 410mg/L.
出处 《食品与发酵工业》 CAS CSCD 北大核心 2008年第9期49-53,共5页 Food and Fermentation Industries
基金 长江学者和创新团队发展计划资助(No.IRT0532)
关键词 葡萄糖基抗坏血酸 Α-葡萄糖苷酶 黑曲霉 筛选 ascorbic acid glucoside, α-glucosidase, AspergilIus niger, screen
  • 相关文献

参考文献12

二级参考文献55

  • 1田辉,杨国武,徐颐玲,谢伯泰.环状糊精与环状糊精葡萄糖基转移酶[J].工业微生物,1995,25(2):33-38. 被引量:16
  • 2[2]Hideki T., Keisuke O., Kohi S., et al. Enhancement of developmental competence after in vitro fertilization of porcine oocytes by treatment with ascorbic acid 2-O-α-glucoside during in vitro maturation. Biology of reproduction, 2001, 65:1800 - 1806
  • 3[4]Yamamoto I., Muto N., Murakami K., et al. Collagen synthesis in human skin fibroblasts is stimulated by a stable form of ascorbate, 2-O-alpha-D-glucopyranosyl-L-ascorbic acid. Nutrition, 1992, 122(4): 871-877
  • 4[5]Yamamoto I., Tanaka M., Muto N. Enhancement of in vitro antibody production of murine splenocytes by ascorbic acid 2-O-alpha-glucoside. International Journal of Immunopharmacology,1993, 15(3): 319- 325
  • 5[6]Miyai E., Yanagida M., Akiyama J., et al. Ascorbic acid 2-O-alpha-glucoside-induced redox modulation in human keratinocyte cell line, SCC: mechanisms of photoprotective effect against ultraviolet light B. Biological and Pharmaceutical Bulletin, 1997,20(6): 632 - 636
  • 6[7]Miyai E., Yanagida M., Akiyama J., et al. Ascorbic acid 2-O-alpha-glucoside, a stable form of ascorbic acid, rescues human keratinucyte cell line, SCC, from cytotoxicity of ultraviolet light B.Biological and Pharmaceutical Bulletin, 1996, 19(7) :984 - 987
  • 7[8]Yamamoto I., Muto N., Murakami K., et al. L-ascorbic acid alpha-glucoside formed by regioselective transglucosylation with rat intestinal and rice seed alpha-gluosidases: its improved stability and structure determination. Chemical and Pharmaceutical Bulletin(Tokyo), 1990, 38(11 ): 3020 - 3023
  • 8[9]KumaroY., SakamotoT., EgawaM. etal. In vitro and in vivo prolonged biological activities of novel vitamin C derivative, 2-O-α-D-glucopyranosyl-L-ascorbid acid ( AA-2G ), in cosmetic fields. Journal of Nutritional Science Vitaminol (Tokyo), 1998,44(3) :345 - 359
  • 9[10]http:∥www. hayashibara.co.jp/eng/index.html
  • 10[11]Itaru Y., NoriM., Toshio M. α-glucosyl-L-ascorbid acid, and it's preparation and uses. United States Patent5767149, 1998-06-16

共引文献42

同被引文献35

引证文献4

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部